封面
市场调查报告书
商品编码
1482459

全球桑格定序市场:按类型、按应用、按最终用途、按地区

Global Sanger Sequencing Market, By Type, By Application, By End-use, and Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球桑格定序市场规模将达31.499亿美元,2024年至2031年复合年增长率为18.2%,2031年将达101.306亿美元。

报告范围 报告详情
基准年 2023年 2024年市场规模 31.499 亿美元
实际资料 2019-2023 预测期 2024-2031
预测 2024-2031 年复合年增长率: 18.20% 2031 年金额预测 101.306 亿美元
图:2024 年按地区分類的桑格定序全球市场占有率(%)
全球桑格定序市场-IMG1

桑格定序,也称为链终止或双脱氧定序,是一种基于体外 DNA 复製过程中 DNA聚合酵素选择性掺入链终止双脱氧核苷酸的 DNA 定序技术。这项技术由英国生物化学家 Frederick Sanger 于 1977 年开发,彻底改变了核酸定序,并促进了遗传学和基因组学的快速发展。桑格定序可产生双向高品质 DNA 序列,被认为是 DNA 定序的黄金标准。

市场动态:

全球桑格定序市场主要是由医疗保健、生物技术和学术研究等各行业对准确且经济高效的 DNA 定序的需求不断增长所推动。导致自动化和高通量的持续技术进步正在扩大桑格定序的应用。例如,许多次世代定序平台利用短桑格读取进行组装。然而,高资本投资要求和复杂的工作流程为市场成长带来了挑战。新的定序技术可能会透过降低成本和增加产能来扰乱市场。也就是说,桑格定序预计将继续在需要长而准确读取的利基应用中发挥重要作用。市场参与企业正致力于透过合作研究扩大产品系列扩大地域范围。

本研究的主要特点

  • 该报告对全球桑格定序市场进行了详细分析,包括以2023年为基准年的预测期(2024-2031年)的市场规模(百万美元)和年复合成长率(CAGR%)。
  • 它阐明了各个细分市场的潜在收益成长机会,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数,介绍了全球桑格定序市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球桑格定序市场迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球桑格定序市场的各种策略矩阵,将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 最近的趋势
  • 监管场景
  • 製造商收益
  • 价格分析
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第 4 章 全球桑格定序市场 - COVID-19 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球桑格定序市场:按类型划分,2019-2031(百万美元)

  • 霰弹枪定序
  • 标靶基因定序
  • 其他的

第六章全球桑格定序市场:按应用划分,2019-2031(百万美元)

  • 诊断
  • 个人化医疗
  • 法医学
  • 其他的

第 7 章 全球桑格定序市场:依最终用途分类,2019-2031 年(百万美元)

  • 政府研究所
  • 诊断实验室
  • 製药和生物技术公司
  • 其他的

第8章全球桑格定序市场:依地区划分,2019-2031(百万美元)

第9章 竞争格局

  • 公司简介
    • Eurofins Scientific
    • CeMIA
    • Fasteris SA
    • GENEWIZ
    • GenHunter Corporation
    • GenScript
    • LGC Biosearch Technologies
    • Nucleics
    • Quintara Biosciences
    • SciGenom Labs Pvt. Ltd
    • StarSEQ GmbH
    • Thermo Fisher Scientific Inc.
    • QIAGEN
    • Promega Corporation
    • Source BioScience

第10章分析师建议

第十一章 参考文献与调查方法

简介目录
Product Code: CMI6927

Global sanger sequencing market is estimated to be valued at USD 3,149.9 Mn in 2024, and is expected to reach USD 10,130.6 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 18.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 3,149.9 Mn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 18.20% 2031 Value Projection: US$ 10,130.6 Mn
Figure. Global Sanger Sequencing Market Share (%), By Region 2024
Global Sanger Sequencing Market - IMG1

Sanger sequencing, also known as chain termination or dideoxy sequencing, is a method for DNA sequencing based on the selective incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication. This technique, developed by a British biochemist, Mr. Frederick Sanger in 1977, revolutionized DNA sequencing and enabled rapid progress in genetics and genomics. Sanger sequencing produces high-quality DNA sequences in both directions and is considered the gold standard for DNA sequencing.

Market Dynamics:

The global sanger sequencing market is predominantly driven by the increasing demand for accurate and cost-effective DNA sequencing across various industries such as healthcare, biotechnology, academic research, etc. Continuous technological advancements leading to automation and higher throughput are expanding the applications of Sanger sequencing. For example, many next-generation sequencing platforms rely on short Sanger reads for assembly. However, high capital investment requirements and complex workflow pose challenges for market growth. Emerging sequencing technologies threaten to disrupt the market through lower costs and higher capacity. Nonetheless, sanger sequencing is expected to remain relevant in niche applications that require long and accurate reads. Market players are focused on product portfolio expansion and geographic expansion through collaborations.

Key Features of the Study:

  • This report provides an in-depth analysis of the global sanger sequencing market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global sanger sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study Eurofins Scientific, CeMIA, Fasteris SA, GENEWIZ , GenHunter Corporation, GenScript , LGC Biosearch Technologies, Nucleics , Quintara Biosciences, SciGenom Labs Pvt. Ltd, StarSEQ GmbH, Thermo Fisher Scientific Inc., QIAGEN, Promega Corporation, Source BioScience.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global sanger sequencing market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sanger sequencing market.

Detailed Segmentation-

  • By Type:
    • Shotgun Sequencing
    • Targeted Gene Sequencing
    • Others
  • By Application:
    • Diagnostics
    • Personalized Medicine
    • Forensics
    • Others
  • By End-use:
    • Government Research Institutes
    • Diagnostic Labs
    • Pharmaceutical and Biotechnology Company
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Eurofins Scientific
    • CeMIA
    • Fasteris SA
    • GENEWIZ
    • GenHunter Corporation
    • GenScript
    • LGC Biosearch Technologies
    • Nucleics
    • Quintara Biosciences
    • SciGenom Labs Pvt. Ltd
    • StarSEQ GmbH
    • Thermo Fisher Scientific Inc.
    • QIAGEN
    • Promega Corporation
    • Source BioScience

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By End-use
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Pricing Analysis
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Sanger Sequencing Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 impact on the market

5. Global Sanger Sequencing Market, By Type, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Shotgun Sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Targeted Gene Sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Sanger Sequencing Market, By Application, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Personalized Medicine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Forensics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Sanger Sequencing Market, By End-use, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Government Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Diagnostic Labs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Pharmaceutical and Biotechnology Company
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Sanger Sequencing Market, By Region, 2019 - 2031, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-use, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Eurofins Scientific
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CeMIA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fasteris SA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GENEWIZ
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GenHunter Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GenScript
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LGC Biosearch Technologies
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nucleics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Quintara Biosciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SciGenom Labs Pvt. Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • StarSEQ GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • QIAGEN
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Promega Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Source BioScience
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact